Wskazniki toksykologiczne stosowane do oceny ryzyka zdrowotnego narazenia na substancje chemiczne Cz.I. Ocena ryzyka zdrowotnego narazenia na substancje niekancerogenne
1. Guidelines for carcinogen risk assessment US EPA 600/8- 87/045, Washington DC 1987.
2. Guidelines for mutagenicity risk assessment US EPA 600/8-87/045, Washington DC 1987.
3. Guidelines for the health assessment of suspect developmental toxicants US EPA 600/8-87/046, Washington DC, 1987.
4. Proposed amendments to guidelines for the health assessment of suspect developmental toxicants. 54 Fed. Regist. 9386, 6 marzec 1989 US EPA 1985.
5. Manson J.M.: Developmental toxicity of alkylating agents: Mechanism of action, str. 95-129 w. M.R. Jackson ed. The biochemical basis of chemical teratogenesis. Elsevier/North-Holland, New York 1981.
6. Risk assessment guidance for Superfund V. 1. Human health evaluation manual. Part A. Interim Final US EPA 540/1-89/002 Washington DC. 1989.
7. Registry of toxic effects of chemical substances (RTECS), NIOSH, Cincinnati 1990.
9. Tardiff R.G., Rodricks J.V.: Comprehensive risk assessment w. Toxic substances and human risk str. 391-434 ed. Tardiff R.G., Rodricks J. V. Plenum Press, New York, London 1982.
10. National Research Council. Principles for evaluation chemicals in the environment. A report of the committee for the Working Conference on Principles of Protocols for Evaluating Chemicals in the Environment National Academy Press, Washington DC. 1975.
11. US EPA. Guidelines and methodology used in the preparation of health effects assessment chapter ofthe consent decree water quality criteria. Fed. Regist. 45,79347-79357,1980.
12. Dourson M.L., Stara J.F.: Reg. Toxicol.Pharmacol. 3, 224 (1983).
13. Reference dose (RfD): Description and use in health risk assessment. Integrated Risk Information System (IRIS) US EPA 1987.
14. FAO/WHO. Toxicological evaluation of certain food additives in a review of general principles and specifications. Technical Report Series No 539. World Healt Organization Geneva, 1974.
16. Krasovskii G.N.: Environ. Health Perspect. 13, 51 (1976).
17. Dedrick R.L.: J. Pharm. Sci. 75,1047 (1047 (1986).
18. Calabrese E.J.: Pharm. Sci. 75,1041 (1986).
19. MordentiJ.:S. Pharm. Sci. 75,1028 (1986).
20. Anderson E.L. and Carcinogen Assessment Group (CAS) ofthe US EPA. Risk Analysis 3, 277 (1983).
21. Materiały szkoleniowe kursu „Environmental health risk assessment" w IMP Łódź pod egidą US EPA i University of Cincinnati College of Medicine, Marzec-Kwiecień 1993.
22. Weil C.S.: Toxicol. Appl. Pharmacol. 21, 454 (1972).
27. Hattis D„ Lewis S.C.: Toxicologist. 12,23 (1992).
28. McNamara B.P.: Concept in health evaluation of commercial and industrial chemicals, w. New concepts in safety evaluation, str. 61-140, wyd. M.A. Mehlman, R.E. Shapiro, H. Blumenthal. Hemisphere Publ. Washington DC. 1976.
29. Drinking Water and Health, tom, 9, str. 121 - 133 NAS, Safe Drinking Water Committee, National Academy Press, Washington DC. 1989.